ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Tracking leukemia with minimal residual disease (MRD)"
Episode Synopsis
Leukemia includes many different disease types, and unlike most solid tumors, it requires unique approaches to monitor how well treatment works. Naveen Pemmaraju, M.D., and Fadi Haddad, M.D., explain how minimal residual disease, or MRD, is helping doctors monitor leukemia more precisely and personalize treatment. Learn how it’s used across leukemia types and what the future of MRD research could mean for patients.
More episodes of the podcast Cancerwise Podcast
Facing cancer during the holidays
19/11/2025
Body image after breast cancer surgery
30/09/2025
How to talk to your children about vaping
27/08/2025
How to support someone facing cancer
29/07/2025
In God we trust